Infusion Pump News and Research

RSS

Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson's disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.

15 Mar 2024

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas-;a wearable, pocket-sized, automated insulin delivery device-;that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

Algorithms can assess unconsciousness under general anesthesia with accuracy and reliability

Anesthestic drugs act on the brain but most anesthesiologists rely on heart rate, respiratory rate, and movement to infer whether surgery patients remain unconscious to the desired degree.

7 May 2021

FEFU scientists suggest reconsidering existing treatment protocol for severe spinal cord trauma

Scientists from Far Eastern Federal University together with leading international experts suggest reconsidering the existing treatment protocol for severe spasticity, one of the main complications after spinal cord injury with partial spinal cord disruption.

10 Dec 2020

'Fuzzy logic' alarm system may help nurses in NICU predict impending catheter infusion failure

A "fuzzy logic" alarm system may help nurses in the neonatal intensive care unit predict impending catheter infusion failure – and prevent complications in critically ill newborns, reports a study in the October issue of Advances in Neonatal Care, official journal of the National Association of Neonatal Nurses.

11 Dec 2019

'Fuzzy logic' alarm system may help NICU nurses predict catheter infusion failure

A "fuzzy logic" alarm system may help nurses in the neonatal intensive care unit (NICU) predict impending catheter infusion failure – and prevent complications in critically ill newborns, reports a study in the October issue of Advances in Neonatal Care, official journal of the National Association of Neonatal Nurses.

20 Nov 2019

Diabetes data analysis will lead to better blood sugar monitoring and insulin delivery

The lives of people with Type 1 diabetes could be significantly enhanced through algorithms that connect glucose monitors and insulin pumps to automatically regulate blood glucose to healthy levels, in the same fashion that cruise control in an automobile regulates speed.

13 Aug 2019

FDA authorizes new interoperable insulin pump for children, adults with diabetes

The U.S. Food and Drug Administration today permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes.

15 Feb 2019

FDA warns against use of unapproved pain medications with implanted pumps

The U.S. Food and Drug Administration today alerted health care providers and patients about the serious complications that can occur when using medications not approved for use with implanted pumps that deliver medication into the spinal fluid to treat or manage pain.

15 Nov 2018

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.

17 Aug 2018

Study demonstrates potential nanoparticle-based therapeutic strategy for deadly brain tumors

Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating deadly glioblastoma brain tumors.

13 Jul 2017

BD introduces new safety solution to help prevent IV medication administration errors

BD (Becton, Dickinson and Company), a leading global medication technology company, announced today the availability of its new IV Medication Safety Solution, designed to help to measurably prevent IV medication administration errors.

From BD (Becton, Dickinson and Company) 24 Mar 2017

Lilly receives FDA approval for Humulin R U-500 KwikPen

The U.S. Food and Drug Administration has approved Eli Lilly and Company's Humulin R U-500 KwikPen(insulin human injection) 500 units/mL, a pre-filled device containing Humulin R U-500, a highly concentrated formulation of insulin.

21 Jan 2016

Researchers to undertake long-term clinical trial of artificial pancreas system for type 1 diabetes patients

Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the so-called artificial pancreas system performs in patients as hoped, it could lead to commercial trials and eventual regulatory approval in the United States and abroad.

5 Jan 2016

New collaboration aims to develop novel generation artificial pancreas

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern - and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital "Inselspital" are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas.

24 Nov 2015

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

"We are pleased to receive positive CHMP opinions for Kyprolis and BLINCYTO as this is an important step in providing new treatment options for patients in Europe with rare forms of cancer," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen.

25 Sep 2015

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen and Xencor, Inc. announced today that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.

16 Sep 2015

WellSpan Health, CareFusion announce successful implementation of Alaris System in WellSpan hospitals

WellSpan Health and CareFusion, a BD company, today announced the successful implementation of the Alaris System across all four WellSpan hospitals, with WellSpan York Hospital becoming the first hospital ever to simultaneously go-live with new infusion devices and bi-directional interoperability between the infusion device and the electronic health record (EHR).

10 Jun 2015

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.

29 May 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim)‎ studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.

28 May 2015